Your session is about to expire
← Back to Search
Behavioural Intervention
Recovery Legal Care for Traumatic Injury (HVIP-MLP Trial)
N/A
Waitlist Available
Led By TANYA L ZAKRISON, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 14-64 years
Be younger than 65 years old
Must not have
Unable to provide informed consent due to mental status
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 12 months, 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to evaluate a new program that combines a Hospital-Based Violence Intervention Program (HVIP) with a Medical Legal Partnership (MLP) to address the social and structural determinants of health that
Who is the study for?
This trial is for individuals who have experienced a traumatic injury, such as a gunshot wound, and are facing financial difficulties or systemic racism. To join, they must be part of an HVIP program at a US trauma center.
What is being tested?
The study tests the effectiveness of adding Recovery Legal Care to standard HVIP care. This new approach provides legal assistance at the bedside to address social and structural issues contributing to violent injuries.
What are the potential side effects?
Since this trial involves legal care rather than medical treatment, traditional physical side effects are not applicable. However, participants may experience emotional or psychological responses related to discussing their traumatic experiences.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 14 and 64 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am unable to understand and give consent for treatment due to my mental condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months, 12 months, 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 12 months, 18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Firearm victimization and aggression
Secondary study objectives
Health-related quality of life
Legal needs self-efficacy
Post-Traumatic Stress Disorder (PTSD) Symptoms
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: HVIP-MLPExperimental Treatment2 Interventions
This arm includes patients receiving usual care and also support from Recovery Legal Care (HVIP+MLP)
Group II: HVIPActive Control1 Intervention
This arm includes patients receiving usual care (HVIP only).
Find a Location
Who is running the clinical trial?
U.S. Department of JusticeFED
20 Previous Clinical Trials
86,124 Total Patients Enrolled
University of ChicagoLead Sponsor
1,056 Previous Clinical Trials
760,283 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,056 Previous Clinical Trials
2,737,644 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger